Encouraged by these data and previous reports on TNF-α blockade to improve anti-PD-1 therapy efficacy in a mouse model of melanoma and colon carcinoma (33, 34), we evaluated the therapeutic potential of TNF-α and PD-L1 co-blockade in the LLC-Fluc model. The gene discussed is TNF; the disease is melanoma.